Bonnie Discepolo participated in an clinical trial examining possibly delaying menopause to improve health outcomes. She hopes it gives women more agency. Williams is leading a study to understand the impact of slowing ovarian age on women’s health. The double-blind study looks at 100 women between 35 and 45 who have normal periods. (Double-blind means no one knows who receives the treatment and who receives the placebo.) Subjects are randomized to receive either rapamycin or a placebo. For three months, participants take a pill, and researchers will follow them for another nine months. https://www.today.com/health/womens...womens-health-1-woman-shares-story-rcna148425
